Medications and treatments Archive

Semaglutide, a GLP-1 agonist used to treat diabetes and obesity, may also help people with metabolic dysfunction-associated steatohepatitis, a severe stage of fatty liver disease, suggests a 2025 study.

Topical painkillers might be safer than pills to relieve discomfort from muscle strains (like a pulled hamstring) or ligament sprains (like a sprained ankle). This is because topicals target the area of pain. As a result, other parts of the body are exposed to lower levels of medicine. That's important, since some painkillers, such as nonsteroidal anti-inflammatory drugs (NSAIDs), can pose severe risks-such as heart attack and stroke.

In a 2025 study, researchers estimated that fewer than four emergency department visits attributed to semaglutide (Ozempic, Wegovy) occurred for every 1,000 patients taking the drug in 2022 and 2023. Most of the visits were related to gastrointestinal problems.

A 2025 study suggested that a structured exercise plan can significantly reduce the risk of falls among older women who take multiple medications.

A 2025 study found that a pill version of the drug semaglutide, marketed as Rybelsus, can lower the risk for serious heart problems in people who have diabetes as well as cardiovascular disease, kidney disease, or both.

Metabolic syndrome is defined as having at least three of the following: abdominal obesity, high blood triglyceride levels, high blood pressure, high blood sugar levels, and low HDL cholesterol levels. The condition significantly increases the risk for cardiovascular disease, diabetes, kidney disease, fatty liver disease, and sleep apnea. While each factor is problematic, the main driver is abdominal obesity, from visceral fat surrounding internal organs. The best way to reduce visceral fat is aerobic exercise, strength training, and a plant-based diet.

Using hormone therapy, which involves taking estrogen and sometimes progesterone, doesn't stop or slow the approach of menopause. The arrival of menopause is determined by women's ovaries, not by the amount of these hormones in the body.